CoChat

DHEAS and cortisol/DHEAS-ratio in recurrent depression: State, or trait predicting 10-year recurrence?

Mocking, R.J.T., Pellikaan, C.M., Lok, A., Assies, J., Ruhé, H.G., Koeter, M.W., Visser, I., Bockting, C.L., Olff, M., Schene, A.H. · 2015 · Psychoneuroendocrinology
Cited by 55

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.psyneuen.2015.05.006

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 33

  1. Arnold, 2009, DHEA metabolism in prostate: for better or worse?, Mol. Cell. Endocrinol., 301, 83, 10.1016/j.mce.2008.10.019 · DOI
  2. Assies, 2004, Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings, Psychiatry Res., 128, 117, 10.1016/j.psychres.2004.05.016 · DOI
  3. Assies, 2014, Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity, Acta Psychiatr. Scand., 130, 163, 10.1111/acps.12265 · DOI · Paper page
  4. Bhagwagar, 2008, ‘It's not over when it's over’: persistent neurobiological abnormalities in recovered depressed patients, Psychol. Med., 38, 307, 10.1017/S0033291707001250 · DOI · Paper page
  5. Bicanic, 2013, Salivary cortisol and dehydroepiandrosterone sulfate in adolescent rape victims with post traumatic stress disorder, Psychoneuroendocrinology, 38, 408, 10.1016/j.psyneuen.2012.06.015 · DOI
  6. Bland, 1996, Measurement error proportional to the mean, BMJ, 313, 106, 10.1136/bmj.313.7049.106 · DOI · Paper page
  7. Bockting, 2013, Therapygenetics: the 5HTTLPR as a biomarker for response to psychological therapy?, Mol. Psychiatry, 18, 744, 10.1038/mp.2012.92 · DOI
  8. Bortfeld, 2006, Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system, Neuroscience, 137, 1247, 10.1016/j.neuroscience.2005.10.025 · DOI
  9. Chen, 2015, Tactics for modeling multiple salivary analyte data in relation to behavior problems: additive, ratio, and interaction effects, Psychoneuroendocrinology, 51C, 188, 10.1016/j.psyneuen.2014.09.027 · DOI
  10. Davidson, 2000, Safety and pharmacokinetic study with escalating doses of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy male volunteers, Clin. Invest. Med., 23, 300
  11. Genud, 2009, DHEA lessens depressive-like behavior via GABA-ergic modulation of the mesolimbic system, Neuropsychopharmacology, 34, 577, 10.1038/npp.2008.46 · DOI
  12. Girdler, 2012, A history of depression in women is associated with an altered GABAergic neuroactive steroid profile, Psychoneuroendocrinology, 37, 543, 10.1016/j.psyneuen.2011.08.004 · DOI · Paper page
  13. Heuser, 1998, Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients, J. Clin. Endocrinol. Metab., 83, 3130, 10.1210/jcem.83.9.5081 · doi:10.1210/jcem.83.9.5081 · Paper page
  14. Hsiao, 2006, Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression, Psychoneuroendocrinology, 31, 839, 10.1016/j.psyneuen.2006.03.008 · DOI
  15. Hsiao, 2011, The long-term effects of psychotherapy added to pharmacotherapy on morning to evening diurnal cortisol patterns in outpatients with major depression, Psychother. Psychosom., 80, 166, 10.1159/000321558 · DOI · Paper page
  16. Key, 2002, Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies, J. Natl. Cancer Inst., 94, 606, 10.1093/jnci/94.8.606 · DOI · Paper page
  17. Kurita, 2013, Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls, J. Affect. Disord., 146, 205, 10.1016/j.jad.2012.09.004 · DOI
  18. Lennartsson, 2013, Perceived stress at work is associated with attenuated DHEA-S response during acute psychosocial stress, Psychoneuroendocrinology, 38, 1650, 10.1016/j.psyneuen.2013.01.010 · DOI
  19. Markopoulou, 2009, The ratio of cortisol/DHEA in treatment resistant depression, Psychoneuroendocrinology, 34, 19, 10.1016/j.psyneuen.2008.08.004 · DOI
  20. Michael, 2000, Altered salivary dehydroepiandrosterone levels in major depression in adults, Biol. Psychiatry, 48, 989, 10.1016/S0006-3223(00)00955-0 · DOI · Paper page
  21. Morita, 2014, Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants, Hum. Psychopharmacol., 29, 280, 10.1002/hup.2400 · DOI
  22. Mouthaan, 2014, The role of acute cortisol and DHEAS in predicting acute and chronic PTSD symptoms, Psychoneuroendocrinology, 45, 179, 10.1016/j.psyneuen.2014.04.001 · DOI
  23. Paslakis, 2010, Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment, J. Psychiatr. Res., 44, 556, 10.1016/j.jpsychires.2009.11.015 · DOI
  24. Peixoto, 2014, The effects of dehydroepiandrosterone (DHEA) in the treatment of depression and depressive symptoms in other psychiatric and medical illnesses: a systematic review, Curr. Drug Targets, 15, 901, 10.2174/1389450115666140717111116 · DOI
  25. Ritsner, 2007, State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients, Eur. Neuropsychopharmacol., 17, 257, 10.1016/j.euroneuro.2006.09.001 · DOI
  26. Ruhé, 2015, Longitudinal effects of the SSRI paroxetine on salivary cortisol in major depressive disorder, Psychoneuroendocrinology, 52, 261, 10.1016/j.psyneuen.2014.10.024 · DOI · Paper page
  27. Sakr, 2014, Effect of dehydroepiandrosterone (DHEA) on memory and brain derived neurotrophic factor (BDNF) in a rat model of vascular dementia, J. Physiol. Pharmacol., 65, 41
  28. Schule, 2009, Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients, J. Psychiatr. Res., 43, 538, 10.1016/j.jpsychires.2008.07.003 · DOI
  29. Sripada, 2013, DHEA enhances emotion regulation neurocircuits and modulates memory for emotional stimuli, Neuropsychopharmacology, 38, 1798, 10.1038/npp.2013.79 · DOI
  30. Stewart, 2006, Aging and fountain-of-youth hormones, N. Engl. J. Med., 355, 1724, 10.1056/NEJMe068189 · DOI
  31. Whetzel, 2010, Measuring DHEA-S in saliva: time of day differences and positive correlations between two different types of collection methods, BMC Res. Notes, 3, 204, 10.1186/1756-0500-3-204 · DOI
  32. Young, 2002, Elevation of the cortisol–dehydroepiandrosterone ratio in drug-free depressed patients, Am. J. Psychiatry, 159, 1237, 10.1176/appi.ajp.159.7.1237 · DOI · Paper page
  33. Zelcer, 2003, Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4), Biochem. J., 371, 361, 10.1042/bj20021886 · DOI · Paper page

Cited by

See all 55

Metadata

Authors
Mocking, R. J. T., Pellikaan, C. M., Lok, A., Assies, J., Ruhé, H. G., Koeter, M. W., Visser, I., Bockting, C. L., Olff, M., & Schene, A. H.
Venue
Psychoneuroendocrinology
Publisher
Elsevier BV
Published
2015-09
Volume
59
Pages
91-101
ISSN
0306-4530
Cited by
55
References
19
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.